Navigation Links
VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA®
Date:12/14/2010

MOUNTAIN VIEW, Calif., Dec. 14, 2010 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that the company, as part of its continuing effort to secure regulatory approval for QNEXA® in the U.S., submitted a briefing document to the Food and Drug Administration (FDA) designed to address items in the FDA's Complete Response Letter (CRL), issued on October 28, 2010.  The company also announced that the Endocrine and Metabolic Division of the FDA has granted VIVUS a meeting in the second half of January 2011 to discuss the content of the proposed resubmission.

VIVUS is pursuing regulatory approval to market QNEXA (phentermine/topiramate) Controlled Release Capsules in the U.S. for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.

"Submission of our briefing document and confirmation of our meeting with the FDA indicate the continued progress VIVUS is making in seeking U.S. approval of QNEXA® for the treatment of obesity," said Leland Wilson, chief executive officer of VIVUS. "We are confident in the data analyses we have compiled in the briefing document, and we look forward to our meeting with the FDA."

About QNEXA Controlled Release Capsules

QNEXA [kyoo-nek-suh] is an investigational drug being developed to address weight loss, type 2 diabetes and obstructive sleep apnea. QNEXA is a once-a-day, proprietary, oral, controlled-release formulation of low-dose phentermine and topiramate, which together decrease appetite and increase satiety (the sense of feeling full), the two main mechanisms that impact eating behavior. In phase 2 and 3 clinical data to date, patients taking QNEXA have demonstrated statistically significant weight loss,
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VIVUS to Present at Two Upcoming Investor Conferences
2. VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results
3. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
4. VIVUS Announces Sale of MUSE Assets to Meda
5. VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
6. VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
7. VIVUS to Present at Lazard Capital Markets Healthcare Conference
8. VIVUS Announces Promotion of Peter Tam to President
9. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
10. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
11. Results From Phase 3 EQUATE Trial of VIVUS Qnexa Highlighted at European Congress on Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015 /CNW/ - ... seized a health product being injected at Art Nails Ltd., ... which appeared to be unauthorized as it contained no labelling. All ... be authorized by Health Canada and must have approved labelling. ... that had been administered to consumers. Potential risks associated with injecting ...
(Date:3/3/2015)... , March 3, 2015 ... 356 and 240 patients respectively Publications in ... Journal of Clinical Gastroenterology highlight diagnostic value of ... China and across ... Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the ...
(Date:3/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/x5lz9r/global_poc ) ... Diagnostics Market 2015-2019" report to their offering. ... Diagnostics market to grow at a CAGR of 8.47 ... diagnostics are IVD devices and tools used for diagnosing ... use of these devices helps in the rapid diagnosis ...
Breaking Medicine Technology:Advisory - Health product seized from Art Nails in Vancouver 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 3Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 4Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2
(Date:3/4/2015)... Whatever one's feelings about the Fifty Shades of ... Everyone from hard-core fans of the trilogy, to people in ... hasn't read even one of the books, is putting their ... the general manager of HUSH, a leading retailer of adult ... very good thing. , "When the books came out in ...
(Date:3/4/2015)... The defibrillators report provides insights into the growth ... the global market is expected to grow at a ... by 2019. It expects the emerging markets to provide ... established players in the market. , According to the ... at the highest CAGR during the next five years. ...
(Date:3/4/2015)... TheraBreath is proud to announce a new probiotic lozenge ... with overall health. , Many health experts agree that ... bad bacteria that can cause unwanted infections. While most people ... will need the help of a probiotic to elevate the ... Packed with the S. salivarius M18 & K12 strains of ...
(Date:3/4/2015)... 2015 Follow us on ... growth worldwide, supported by the numerous intraoperative, and ... and single incision surgery will continue to spur ... invasive surgery, driving its adoption among patients and ... site, lower blood loss, shorter hospital stays, faster ...
(Date:3/4/2015)... 2015 Durrie Vision, a ... first in the region to offer two new intraocular ... cataracts. The implantable Tecnis® Multifocal lenses – now offered ... at a range of distances. Earlier this year the ... of two new IOLs – the Tecnis® Multifocal +2.75D ...
Breaking Medicine News(10 mins):Health News:Fifty Shades of Grey™ Has Canadians Talking About Sex. 2Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 2Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 3Health News:TheraBreath introduces a new line of probiotic lozenges that strengthen the body’s ability to fight germs 2Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Durrie Vision First in Region to Offer New Tecnis® Multifocus Lenses 2
... than half of Americans know two particular fats boost ... Fewer than half of Americans realize there are two ... a new survey shows. , So, while many have ... fats and saturated fats, the American Heart Association (AHA) ...
... specific pieces of non-coding genetic material known as microRNAs ... cancer to other parts of the body. Researchers at ... Ohio State University Medical Center in Columbus have identified ... The findings, reported at the annual meeting of the ...
... ... Center, ... planning and interiors,firm, has transformed a shuttered South of Market warehouse ... As the new "front door" for the downtown university, the,former Swallow ...
... Indiana experienced a 50 percent membership ... growth since 2007, ... this 14-year-old, not-for-profit,Indiana managed health care plan -- surpassing the 300,000 mark ... 2007, the,company has also grown its employee base by 182 percent -- ...
... CHAPEL HILL, N.C., May 30 Creating an ... of a new product,s introduction.,A product,s promotion relies ... it.,Top benchmark companies ensure that they create effective, ... of a new product., The detailed report ...
... 30 Members of District,1199C of the National ... morning (Friday) ratified a four-year contract agreement with,Hahnemann ... increase in,wages and benefits., District 1199C represents ... reached with the hospital following some 16 and ...
Cached Medicine News:Health News:Some Fats Deserve Change of Heart 2Health News:Jefferson, Ohio State team find gene signature profile for metastasis 2Health News:Golden Gate University Opens New Student Services Center 2Health News:MDwise Enrollment Exceeds 300,000 Members 2Health News:Managing Cross-Functional Teams for Pharmaceutical Product Commercialization Excellence 2
Inquire...
Inquire...
Agarose I (Molecular Biology Grade) - A regular melting temperature agarose for electrophoresis requiring an exceptional level of purity with unequaled performance....
... Biology Grade, is used for ... acids. It can be used ... 0.2 to 40 kb., Each ... tested and certified to be ...
Medicine Products: